SOMATULIN AUTOGEL Inj. Lös 60 mg Fertspr

SOMATULINE AUTOGEL Inj Lös 60 mg Fertspr

SOMATULINE AUTOGEL is a medicinal product used to treat acromegaly and gastroenteropancreatic neuroendocrine tumours (GEP-NETs). It is presented as a solution for injection that contains 60mg of the active ingredient lanreotide.

Lanreotide is a synthetic analogue of somatostatin, a hormone that regulates various physiological processes throughout the body. SOMATULINE AUTOGEL mimics the actions of somatostatin and is used to control the production of growth hormone and other hormones that are overproduced in acromegaly and GEP-NETs.

SOMATULINE AUTOGEL is administered by subcutaneous injection every 28 days by a healthcare professional. The injection is given into the fatty tissue underneath the skin and the dose may be adjusted according to the individual needs of the patient.

The product is supplied in a pre-filled syringe with a special injection system called the Autogel system. This allows for easy and convenient administration of the injection and eliminates the need for reconstitution or handling of the product by the patient or caregiver.

Common side effects of SOMATULINE AUTOGEL include injection site reactions, gastrointestinal symptoms, and changes in glucose metabolism. Serious side effects are rare but may include allergic reactions, gallstones, and pancreatitis.

If you have been prescribed SOMATULINE AUTOGEL, it is important to follow your healthcare provider's instructions carefully and attend all scheduled appointments.